Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
ONL Therapeutics randomizes first patient in phase 2 GALAXY trial evaluating xelafaslatide | Ophthalmology Times
(Image Credit: AdobeStock/Kirsten D) ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY (NCT06659445) trial evaluating xelafaslatide (formerly ONL1204) in patients with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD). According to the…
NeuroOp Guru: Live from AAO 2025 | Ophthalmology Times
Andrew G. Lee, MD, was joined by Drew Carey, MD, for a live recording of the Ophthalmology Times “NeuroOp Guru” during the American Academy of Ophthalmology 2025 annual meeting, held October 18-20, in Orlando, Florida. They discussed an instructive case…
Advancements in femtosecond laser technology benefit surgeons and patients | Ophthalmology Times
(Image Credit: AdobeStock/Wirestock) The field of refractive surgery has undergone multiple technological developments aimed at enhancing patient outcomes, optimizing workflows, and improving patient satisfaction. The VisuMax laser platform (Zeiss) is among the commercially available femtosecond laser systems and is used…
Bimatoprost drug pad-IOL system shows reduction in mean IOP at 24 months | Ophthalmology Times
Image credit: AdobeStock/oz Interim 24-month data from a trial of the bimatoprost drug pad-IOL system (BIM-IOL system) showed sustained improvements in intraocular pressure (IOP) and visual acuity outcomes.1 The BIM-IOL system has been developed by SpyGlass Pharma, Inc. The company…
What if? Ophthalmology without OCT – Part 1 | Ophthalmology Times
In celebration of Ophthalmology Times‘ 50th anniversary, we asked leading experts what the practice would look like today had optical coherence tomography (OCT), one of the biggest innovations in the field, never been invented. Video Transcript: Editor’s note: The below…
Porter Ophthalmology Clarifies Long-Term Vision Planning for LASIK Patients Considering Cataract Surgery
Raleigh, NC – October 27, 2025 – PRESSADVANTAGE – With millions of Americans having undergone LASIK vision correction in the past three decades, a growing number are now approaching the age where cataract surgery becomes a consideration. Porter Ophthalmology, a…
AAO 2025: Ophthalmic World Leaders honors 2025 leadership awardees | Ophthalmology Times
From left: Cherie Fathy, MD, MPH, and Cathleen McCabe, MD. Leo E. Otero, MBA, was traveling internationally and unable to attend the ceremony. (Photo Credit: Pam Katz Photography) Ophthalmic World Leaders (OWL) has unveiled its 2025 Leadership Award recipients. The…
Q&A: William F. Wiley, MD, on what BVI’s trifocal IOL approval means for US premium vision options | Ophthalmology Times
The FDA’s approval of the FineVision HP trifocal lens expands the range of premium lens option to US ophthalmologists and their patients. (Image credit: AdobeStock/Margarita Ratatosk) As the landscape of ophthalmic innovation continues to evolve, new technologies are reshaping how…
ICYMI: AAO 2025 showcases new technologies and continued research | Ophthalmology Times
Image credit: AdobeStock/zimmytws The annual scientific meeting of the American Academy of Ophthalmology (AAO) was held in Orlando, Florida. At this meeting, presenters and companies highlighted new technologies and continued areas of research. Ophthalmology Times is highlighting some stories that…
Throwback Series: Managing bilateral diabetic macular edema early in practice | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, leaders revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way such cases are managed today.…